News13.10.05 17:07 Age: 5 yrs
Ipsogen presents breast cancer biomarker results at the European Cancer Conference ECCO 13 Category: Breast Cancer
 Marseille, France, October 13, 2005 – The abstract titled "Utilisation of microarray technology to refine molecular classes and improve clinical management of breast cancer," has been selected by the ECCO 13 Scientific Committee for oral presentation in the Proffered paper session "Molecular characterization of breast cancer and its clinical implications" which will be held on Thursday, 03 November, 2005. Ipsogen SAS, the French cancer diagnostics company, announced today that its latest breast cancer program results had been selected for presentation in a symposium session at the ECCO 13 congress, Europe's pre-eminent cancer research conference, held in Paris from October 30 to November 03.  |
|
